Outpatient adherence to beta-blocker therapy after acute myocardial infarction
Javed Butler, MD, MPH, FACC* ||,*,
Patrick G. Arbogast, PhD ,
Rhonda BeLue, PhD ,
James Daugherty, MS ,
Manoj K. Jain, MD, MPH ,
Wayne A. Ray, PhD || and
Marie R. Griffin, MD, MPH ||
* Department of Medicine, Cardiology Division, Nashville, Tennessee, USA
Center for Health Services Research, Nashville, Tennessee, USA
Department of Preventive Medicine, Vanderbilt University, Nashville, Tennessee, USA
Center for Healthcare Quality, Inc, Nashville, Tennessee, USA
|| Geriatrics Research, Education, and Clinical Center, Nashville VA Medical Center, Nashville, Tennessee, USA

View larger version (15K):
[in a new window]
|
Figure 1 Beta-blocker use after acute myocardial infarction. Use of beta-blockers among patients who were and were not given a prescription for them at discharge. The adherence is shown from discharge to one year postdischarge and includes patients who were alive at any given time period.
|
|
|